Study Purpose:
A multi-center registration study of natural history and clinical characteristics of ALS in mainland ChinaStudy Status:
Not recruiting
Disease:
Amyotrophic Lateral Sclerosis
Study Type:
Observational [Patient Registry]
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Dongsheng Fan, MD, PhD, Peking University Third Hospital
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
Dongsheng Fan, MD, PhD / email hidden; JavaScript is required / +86-15611908107
Full Study Summary:
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease of unknown etiology that is currently incurable. This study is a national multi-center registration study. The study collects general information of ALS patients including medical history, disease characteristics, clinical treatment data, and patient information for different visits in different centers. The aim of the study is: a) describe the distribution of ALS in mainland China(explore the differences in the number of ALS at different times, different regions, and different populations) and further find the reasons that affect the distribution of ALS, b) study the development of ALS in mainland China and the corresponding changes in the characteristics of the disease, c) explore factors that influence the prognosis of ALS.
Study Sponsor:
Peking University Third Hospital
Estimated Enrollment:
4752
Estimated Study Start Date:
03 / 20 / 2020
Estimated Study Completion Date:
03 / 20 / 2023
Posting Last Modified Date:
04 / 28 / 2020
Date Study Added to neals.org:
03 / 31 / 2020
Minimum Age:
18 Years
Maximum Age:
80 Years
Inclusion Criteria:- Clinical diagnosis of laboratory-supported probable, probable, or definite ALS according to EI Escorial diagnostic criteria
- Age: 18-70 years
Exclusion Criteria:
- Refuse to cooperate or reject the informed consent
Peking University Third Hospital | Recruiting
Dongsheng Fan / +861082265032 / email hidden; JavaScript is required
Beijing, Beijing
100191
China